Study to Investigate the Effects of Food on the Pharmacokinetics/Pharmacodynamics of CKD-519

NCT02894541 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2017-02-23

No results posted yet for this study

Summary

The purpose of this study is to investigate the effects of food on the pharmacokinetics/pharmacodynamics of CKD-519.

Conditions

  • Healthy Volunteers

Interventions

DRUG

CKD-519 100mg

DRUG

CKD-519 200mg

DRUG

CKD-519 100mg

DRUG

CKD-519 200mg

Sponsors & Collaborators

  • Chong Kun Dang Pharmaceutical

    lead INDUSTRY

Principal Investigators

  • Ji Young Park, MD, PhD · Korea University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-08-31
Primary Completion
2016-11-30
Completion
2017-01-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02894541 on ClinicalTrials.gov